(Q36413247)

14 August 2017

Patient-derived cell models as preclinical tools for genome-directed targeted therapy (English)

1 reference

14 August 2017

10

Oliver Rath

1 reference

14 August 2017

21

Kyoung-Mee Kim

1 reference

14 August 2017

Ji Yun Lee

1

1 reference

14 August 2017

Sun Young Kim

2

1 reference

14 August 2017

Charny Park

3

1 reference

14 August 2017

Nayoung K D Kim

4

1 reference

14 August 2017

Jiryeon Jang

5

1 reference

14 August 2017

Kyunghee Park

6

1 reference

14 August 2017

Jun Ho Yi

7

1 reference

14 August 2017

Mineui Hong

8

1 reference

14 August 2017

Taejin Ahn

9

1 reference

14 August 2017

Julia Schueler

11

1 reference

14 August 2017

Seung Tae Kim

12

1 reference

14 August 2017

In-Gu Do

13

1 reference

14 August 2017

Sujin Lee

14

1 reference

14 August 2017

Se Hoon Park

15

1 reference

14 August 2017

Yong Ick Ji

16

1 reference

14 August 2017

Dukwhan Kim

17

1 reference

14 August 2017

Joon Oh Park

18

1 reference

14 August 2017

Young Suk Park

19

1 reference

14 August 2017

Won Ki Kang

20

1 reference

14 August 2017

Woong-Yang Park

22

1 reference

14 August 2017

Ho Yeong Lim

23

1 reference

14 August 2017

Jeeyun Lee

24

1 reference

14 August 2017

language of work or name

English

0 references

publication date

16 July 2015

1 reference

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

28

1 reference

14 August 2017

25619-25630

1 reference

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Oncotator: cancer variant annotation tool

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Patient-derived xenograft models: an emerging platform for translational cancer research

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Comprehensive molecular characterization of gastric adenocarcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Influence of tumour micro-environment heterogeneity on therapeutic response

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Patient-derived tumor xenografts: transforming clinical samples into mouse models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Technologies for deriving primary tumor cells for use in personalized cancer therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Molecular profiling of patient-derived breast cancer xenografts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Local regulation of human breast xenograft models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Cancer-associated fibroblasts and tumor growth--bystanders turning into key players

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Mouse xenograft models vs GEM models for human cancer therapeutics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Direct multiplexed measurement of gene expression with color-coded probe pairs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Modeling tissue morphogenesis and cancer in 3D.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

The NCI60 human tumour cell line anticancer drug screen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Three-dimensional tissue culture models in cancer biology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Stromal fibroblasts in cancer initiation and progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Karyotypic complexity of the NCI-60 drug-screening panel.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4694854

MerTK is a novel therapeutic target in gastric cancer

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26296973

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.4627

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

26296973

1 reference